Bank Pictet & Cie (Europe)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
29,605
-201,895
| -87% | -$9.35M | 0.03% | 111 |
|
|
2025
Q1 | $14.1M | Hold |
231,500
| – | – | 0.34% | 61 |
|
|
2024
Q4 | $13.1M | Buy |
+231,500
| New | +$13.1M | 0.29% | 62 |
|
|
2024
Q2 | – | Sell |
-11,250
| Closed | -$610K | – | 159 |
|
|
2024
Q1 | $610K | Hold |
11,250
| – | – | 0.02% | 124 |
|
|
2023
Q4 | $577K | Sell |
11,250
-600
| -5% | -$30.8K | 0.02% | 172 |
|
|
2023
Q3 | $688K | Buy |
11,850
+600
| +5% | +$34.8K | 0.02% | 151 |
|
|
2023
Q2 | $719K | Hold |
11,250
| – | – | 0.02% | 160 |
|
|
2023
Q1 | $780K | Hold |
11,250
| – | – | 0.03% | 114 |
|
|
2022
Q4 | $809K | Hold |
11,250
| – | – | 0.04% | 111 |
|
|
2022
Q3 | $800K | Hold |
11,250
| – | – | 0.04% | 107 |
|
|
2022
Q2 | $866K | Sell |
11,250
-1,600
| -12% | -$123K | 0.04% | 103 |
|
|
2022
Q1 | $938K | Sell |
12,850
-6,475
| -34% | -$473K | 0.04% | 106 |
|
|
2021
Q4 | $1.21M | Buy |
19,325
+786
| +4% | +$49K | 0.04% | 104 |
|
|
2021
Q3 | $1.1M | Sell |
18,539
-363
| -2% | -$21.5K | 0.04% | 103 |
|
|
2021
Q2 | $1.26M | Sell |
18,902
-1,204
| -6% | -$80.4K | 0.04% | 101 |
|
|
2021
Q1 | $1.27M | Sell |
20,106
-392,066
| -95% | -$24.7M | 0.05% | 98 |
|
|
2020
Q4 | $25.6M | Buy |
412,172
+12,172
| +3% | +$755K | 1.25% | 29 |
|
|
2020
Q3 | $24.1M | Hold |
400,000
| – | – | 1.35% | 27 |
|
|
2020
Q2 | $23.5M | Buy |
400,000
+34,340
| +9% | +$2.02M | 1.64% | 25 |
|
|
2020
Q1 | $20.4M | Buy |
365,660
+358,230
| +4,821% | +$20M | 1.85% | 20 |
|
|
2019
Q4 | $477K | Buy |
+7,430
| New | +$477K | 0.07% | 104 |
|